Diabetes Going Undetected in Many Heart Patients
From: Roman Bystrianyk (rbystrianyk_at_gmail.com)
Date: 08/30/04
- Next message: SomeGuy: "Re: How to Become a Christian, Version 1.01"
- Previous message: GaryG: "Re: This just in: Dr. Andrew B. Chung, MD/PhD is untruthful!"
- Messages sorted by: [ date ] [ thread ]
Date: 30 Aug 2004 09:02:08 -0700
http://www.healthsentinel.com/news.php?event=news_print_list_item&id=177
"Diabetes Going Undetected in Many Heart Patients", Reuters, August
30, 2004,
Link: http://www.reuters.com/newsArticle.jhtml?type=healthNews&storyID=6102333
Diabetes is an undetected and silent threat for many people who end up
with heart disease, according to new research published on Monday.
Professor John McMurray, of the Western Infirmary in Glasgow,
Scotland, said the problem was more widespread than previously
realized, highlighting the need for more routine diabetes testing.
Of 43,500 people screened for inclusion into a major heart drug trial
-- of whom only 20 percent already had cardiovascular disease --
approximately 1 in 5 had previously undiagnosed type 2 diabetes,
McMurray told the annual meeting of the European Society of
Cardiology.
And more than 1 in 4 additional subjects had impaired glucose
tolerance, a pre-diabetic condition which frequently progresses to
full-blown diabetes.
Type 2 diabetes, which is the most common form of the illness, results
from the body's inability to respond to the action of insulin produced
by the pancreas. It is strongly linked to being overweight or obese.
McMurray said the rate of hidden diabetes was alarming and showed that
doctors needed to do much more to identify and treat the disease.
Diabetes is linked not only to eye, kidney and nerve damage but also
with much worse outcomes from heart problems and clogged arteries.
McMurray's findings were based on screening of patients, with an
average age of 63 years, for the Navigator study, which is backed by
Novartis. It is investigating whether two Novartis drugs, Diovan and
Starlix, can reduce heart attacks and stroke and prevent the onset of
full diabetes in people with impaired glucose tolerance.
Results from the clinical trial, which aims to enroll a total of more
than 9,000 patients, are expected in 2008.
- Next message: SomeGuy: "Re: How to Become a Christian, Version 1.01"
- Previous message: GaryG: "Re: This just in: Dr. Andrew B. Chung, MD/PhD is untruthful!"
- Messages sorted by: [ date ] [ thread ]
Relevant Pages
|